CalciMedica, Inc. · 3.2/10 — Weak · Updated September 2026
Last updated: September 2026
Factor Snapshot
Invetso Quality Score
🔴 3.2 (Weak)
Core Drivers
No durable moat is evident: The supplied evidence does not show meaningful pricing power, switching costs, network effects, or efficient scale, so the business lacks the kind of structural protection that typically supports long-term compounding.
Capital is not compounding efficiently: Negative returns on invested capital point to value destruction at the operating level, which is the most important drag on long-term investment quality and outweighs the limited signs of balance-sheet restraint.
Financial flexibility is better than the operating quality suggests: Low leverage and strong liquidity reduce near-term distress risk, but they do not offset the absence of a proven earnings engine or scalable reinvestment path.
Peer-relative positioning remains behind stronger global operators: Compared with better peers, CALC lacks visible durability, growth visibility, and scalable economics, leaving it in the lagging tier on overall investment quality.
Key Constraints
Weak growth evidence: There is no convincing multi-year compounding record or clear structural demand tailwind in the provided inputs, so upside depends on a turnaround rather than an already established growth engine.
Scalability is unproven: The available data do not show repeatable operating leverage, recurring revenue characteristics, or a platform-like model, which limits confidence that incremental growth can translate into durable value creation.
Risk is contained, but not enough to change the profile: Liquidity and modest leverage help cushion downside, yet negative profitability and weak capital returns keep the overall asymmetry unfavorable versus stronger peers.
Synthesis
CALC’s overall investment quality is weak because the most important long-term drivers are not in place. The company does have a more resilient balance sheet than many small peers, which reduces immediate financial stress and keeps downside from looking extreme. However, that strength is secondary to the bigger issue that the business does not show durable competitive advantage, efficient capital deployment, or a credible scalable growth engine. The result is a profile where operational quality dominates the assessment, and it is poor enough to outweigh the balance-sheet comfort. Relative to global peers, CALC sits in the lagging tier because it lacks the structural features that usually support sustained compounding. The setup is therefore more dependent on a turnaround than on an already durable investment case.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on CalciMedica, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

